The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.00
Bid: 18.00
Ask: 20.00
Change: 0.00 (0.00%)
Spread: 2.00 (11.111%)
Open: 19.00
High: 19.00
Low: 19.00
Prev. Close: 19.00
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New patent grants

23 May 2019 07:00

RNS Number : 9202Z
Directa Plus PLC
23 May 2019
 

23 May 2019

 

Directa Plus plc

("Directa Plus" or the "Company")

 

New patent grants

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce that the Company has been granted two new patents, for the application of the Company's G+ graphene products.

 

Graphene enhanced golf balls

 

The first is an Italian patent for the use of the Company's G+ graphene in the manufacture of golf balls. The use of the G+ compounds in golf balls, can provide a series of beneficial features that offer opportunities to develop a new generation of golf ball, both for professional and amateur players.

 

Certain G+ compounds will be able to achieve particular qualities when added to golf balls.

 

G+ materials can be used to enhance the hard core of professional golf balls in order to increase the shot distance potential of the ball, without losing lateral control. In addition, G+ can be used in the amateur golf ball market, to guarantee swing and improved control.

 

Preparing Graphene Nanoplatelets

 

The second is a Chinese patent, covering Directa Plus' unique process for the manufacturing graphene nanoplatelets.

Directa Plus's unique exfoliation technology is chemical free, has an extremely high yield, and can be varied to produce graphene nanoplatelets with specific morphologies. This means that G+ products are safe for human health, can be tailor-made to meet customers' needs, and the high-yields create competitive prices.

Additionally, the unique characteristics of the G+ process, allow the Company to enter large supply chains, in turn overcoming important entry barriers into the market.

 

Commenting on the agreement, Giulio Cesareo, Founder and CEO of Directa Plus, said:

 

"I'm very pleased that we were able to secure two new patents. We continue to show how our G+ graphene nanoplatelets can enhance products in various categories, and it is vital that we secure the Intellectual Property rights needed to protect our unique technology in worldwide jurisdictions.

 

"Securing Intellectual Property rights for our technological innovations is a key part of our corporate strategy - across global jurisdictions. The Company's current suite of patents now includes 22 granted, and a further 22 pending approval."

 

"Using our G+ product in golf balls, for both the amateur and professional game is an exciting opportunity to enter a large sporting market. "

 

"Additionally, gaining legal recognition of the Company's proprietary, chemical-free graphene production process in China will allow us to enter into larger Chinese supply chains more easily and overcome these barriers in the future."

 

 

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

 

 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies Will Goode (Corporate Finance)

 

Caspar Shand Kydd (Sales)

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor, Lauren Kettle

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Barnaby Hayward, Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRASEEEEEFUSEFI
Date   Source Headline
28th Feb 20224:50 pmRNSExercise of Options
8th Feb 20225:20 pmRNSHolding(s) in Company
29th Dec 202111:11 amRNSResult of General Meeting & TVR
20th Dec 20217:00 amRNSGrant of EU Patent for Shoe Soles
10th Dec 20215:00 pmRNSPosting of Circular and Notice of General Meeting
10th Dec 202112:10 pmRNSResult of Placing and Subscription
9th Dec 20216:28 pmRNSClose of Bookbuild and Subscription
9th Dec 202112:30 pmRNSProposed Equity Raise
1st Dec 20217:00 amRNSCollaboration on Air and Water Filtration
29th Nov 20217:00 amRNSGrant Award for Industrial Filtration
24th Nov 20217:00 amRNSAward of Green Economy Mark
16th Nov 20217:00 amRNSDirectorate Change
11th Nov 20217:00 amRNSCompany Excellence Awards 2021 - Rising Star Award
1st Nov 20217:00 amRNSLaunch of High Performance Trail Running Shoes
14th Oct 20217:00 amRNSAdditional Italian Government Covid Recovery Loan
11th Oct 20217:00 amRNSInvestor Presentation
7th Oct 20217:00 amRNSReactivation of Decontamination Contract
29th Sep 20217:00 amRNSHalf-year Report
8th Sep 20217:00 amRNSMilan Design Week Showcases New G+ Coatings
9th Aug 20217:00 amRNSEU Grant Award
2nd Aug 20217:00 amRNSItalian Government Covid-19 Recovery Loans
28th Jul 20219:12 amRNSSignificant Tender Win
27th Jul 20217:00 amRNSSilver Medal Win in Shirt Printed by Directa
12th Jul 20217:00 amRNSPublication of peer reviewed scientific paper
23rd Jun 20215:19 pmRNSResult of AGM
23rd Jun 20217:00 amRNSAGM Statement
17th Jun 20213:47 pmRNSAward of Options
7th Jun 20212:05 pmRNSSecond Price Monitoring Extn
7th Jun 20212:00 pmRNSPrice Monitoring Extension
7th Jun 20217:00 amRNSNexTech Batteries Partnership Progresses
26th May 20215:20 pmRNSNotice of AGM
17th May 20217:00 amRNSFinal Results for the Year to 31 December 2020
5th May 20217:00 amRNSGrant of EU Production Process Patent
27th Apr 20217:00 amRNSImproved textile printing with graphene inks
19th Apr 20217:00 amRNSNew Safety Test
9th Apr 20217:00 amRNSAppointment of CFO
29th Mar 20217:00 amRNSEurope-wide Patent Granted for G+ in Golf Balls
18th Mar 20217:00 amRNSTrading Update
9th Mar 20217:00 amRNSSuccessful Absorption Evaluation Test
22nd Feb 20217:00 amRNSSupply and R&D Agreements with NexTech Batteries
10th Feb 202111:05 amRNSSecond Price Monitoring Extn
10th Feb 202111:00 amRNSPrice Monitoring Extension
10th Feb 20217:00 amRNSFlame retardant properties of G+ established
3rd Feb 20217:00 amRNSEU grant to enhance Covid resistant face-masks
29th Jan 20219:05 amRNSSecond Price Monitoring Extn
29th Jan 20219:00 amRNSPrice Monitoring Extension
28th Jan 20214:40 pmRNSSecond Price Monitoring Extn
28th Jan 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSAddition to Decontamination and Recovery Contract
21st Jan 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.